Live Citurgia Biochemicals Share Price Chart
Citurgia Biochemicals Performance
Days Range
| Previous Close | ₹66.67 |
|---|---|
| Open | ₹70 |
| Volume | 250 |
| Day's Range | ₹70.00 - ₹70.00 |
|---|---|
| 52W Range | ₹47.40 - ₹70.00 |
| Market Cap | ₹924.67 Cr |
Citurgia Biochemicals Fundamentals
| ROCE(TTM) | 121.95 |
|---|---|
| P/E Ratio (TTM) | -1400 |
| P/B Ratio | 0 |
| Industry P/E | 40.67 |
| Debt to Equity | -0.94 |
| ROE | 5.72 |
| EPS (TTM) | 0 |
| Dividend Yield | 0 |
| Book Value | -0.74 |
| Face Value | 2 |
| ROCE(TTM) | 121.95 |
|---|---|
| P/E Ratio (TTM) | -1400 |
| P/B Ratio | 0 |
| Industry P/E | 40.67 |
| Debt to Equity | -0.94 |
| ROE | 5.72 |
|---|---|
| EPS (TTM) | 0 |
| Dividend Yield | 0 |
| Book Value | -0.74 |
| Face Value | 2 |
Citurgia Biochemicals Financials
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.12 | 0.08 | 0.11 | 0.29 |
| Profit before tax | -0.12 | -0.08 | -0.11 | -0.29 |
| Operating Profit | -0.12 | -0.08 | -0.11 | -0.29 |
| Net Profit | -0.12 | -0.08 | -0.11 | -0.29 |
| EPS in Rs | 0.01 | -0.01 | 0.00 | 0.00 |
Citurgia Biochemicals Shareholding Pattern
| Held by | Mar 2025 | May 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 99.67% | 99.36% | 99.36% | 99.36% | 99.36% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0% | 0% | 0% | 0% | 0% |
| Public | 0.32% | 0.64% | 0.64% | 0.64% | 0.64% |
About Citurgia Biochemicals
Engaged in the manufacture of citric acid, calcium carbonate and plasticisers, Citurgia Biochemicals Limited was promoted by John E Sturge, UK; Bombay Dyeing and Manufacturing Company; and Sturdia Chemicals. The Promoter, John E Sturge was repayed its entire equity holding in 1987-88, which reduced the equity capital. In 1987-88, it acquired two subsidiaries, Sodality Trading & Agencies and Himgiri Trading & Agencies.
Citric acid is traditionally used in foods, soft drinks, confectionery and drugs. It is also used in textile printing and dyeing, where it provides stable pH conditions for polyester and nylon, acrylic print-curing and cotton-resist printing. The company exports citric acid to the US, Japan, Germany, Australia, Iran, Malaysia, Sri Lanka, etc.
In 1988, the company successfully commissioned an anaerobic effluent- treatment plant to treat the effluents discharged during the manufacture of citric acid. It also increased production capacities by implementing expansion and modernisation schemes.
The modernization of coal fired boiler into a Fluidized Bed Combustion(FBC) coal fired boiler was completed.
The wholly owned subsidiary, Jasper Investments Limited was merged with the Company through the Scheme of Amalgamation, making it effective from October 1, 2002. The lock out was declared at Rishikesh factory, with effect from 29th September, 2003.
After registration of the Company's reference by the Hon'ble Board for Industrial & Financial Reconstruction (BIFR) in May, 2003, the first hearing of BIFR took place on July 19, 2005. In the said hearing, BIFR passed an Order declaring the Company as sick industrial company and also appointed the Union Bank of India as Operating Agency to examine the viability of the Company and formulate a rehabilitation scheme based on the Company's proposal for its revival.
The renovation at the Rishikesh plant started during the year 2007. The Rishikesh Plant for manufacturing of the calcium carbonate which was lying closed for last more than four years was renovated completely was put to production during 2008. The building construction work of residential complex at Rishikesh site was started in the Real Estate Division of the Company in 2010.
The Company's operations at calcium carbonate division remained suspended throughout the year for the want of working capital and clearance from the Uttarakhand Environment Protection and Pollution Control Board. The appeal filed by the Company before Hon'ble Supreme Court against the order of Hon'ble High Court of Uttarakhand granting stay the Rehabilitation Scheme passed by Hon'ble BIFR is still pending.
Parent Organisation
MNC Associate
Managing Director
KASHI NATH
Founded
1974
NSE Symbol
CITURGIBIO
Top Mutual Funds Invested in Citurgia Biochemicals Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Pidilite Industries Ltd | 1,464.9 0.00 (0.00%) | ₹1,49,008.60 | 1,311.1 - 1,574.95![]() |
| SRF Ltd | 2,689.1 10.40 (0.39%) | ₹79,677.51 | 2,570.2 - 3,325.0![]() |
| Linde India Ltd | 6,794.0 4.50 (0.07%) | ₹58,065.45 | 5,242.4 - 7,870.0![]() |
| Gujarat Fluorochemicals Ltd | 3,425.7 14.30 (0.42%) | ₹37,592.87 | 2,916.6 - 4,083.55![]() |
| Godrej Industries Ltd | 1,034.35 8.25 (0.80%) | ₹34,817.20 | 854.05 - 1,390.0![]() |
| Navin Fluorine International Ltd | 6,526.0 138.00 (2.16%) | ₹33,444.65 | 3,566.0 - 6,965.0![]() |
Popular stocks
Citurgia Biochemicals Ltd FAQs
What is the share price of Citurgia Biochemicals Ltd (CITURGIBIO) shares?
Citurgia Biochemicals Ltd (CITURGIBIO) share price as of February 20, 2026, on NSE is Rs 70 (NSE) and Rs 70 (BSE) on BSE.
Can I buy Citurgia Biochemicals Ltd (CITURGIBIO) from Angel One?
Yes, You can buy Citurgia Biochemicals Ltd (CITURGIBIO) shares by opening a Demat account with Angel One.
How do I buy Citurgia Biochemicals Ltd (CITURGIBIO) from Angel One?
Citurgia Biochemicals Ltd (CITURGIBIO) share can be bought through the following modes:
1. Direct investment: You can buy Citurgia Biochemicals Ltd (CITURGIBIO) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Citurgia Biochemicals Ltd (CITURGIBIO) shares.
1. Direct investment: You can buy Citurgia Biochemicals Ltd (CITURGIBIO) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Citurgia Biochemicals Ltd (CITURGIBIO) shares.
What is the market cap of Citurgia Biochemicals?
The market cap of Citurgia Biochemicals is Rs. 924.67 Cr. as of 22/02/2026.


.jpg)


